Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up
ContributorsLundgren, J. D.; Babiker, A.; El-Sadr, W.; Emery, Stéphane; Grund, B.; Neaton, J. D.; Neuhaus, J.; Phillips, A. N.
Published inThe Journal of infectious diseases, vol. 197, no. 8, p. 1145-1155
Publication date2008
Abstract
Keywords
- AIDS-Related Opportunistic Infections/epidemiology/mortality
- Anti-HIV Agents/*administration & dosage
- *CD4 Lymphocyte Count
- Drug Administration Schedule
- HIV/*genetics/*immunology
- HIV Infections/*drug therapy/immunology/mortality/virology
- Humans
- Proportional Hazards Models
- RNA, Viral/*blood
- Treatment Outcome
Affiliation entities
Citation (ISO format)
LUNDGREN, J. D. et al. Inferior clinical outcome of the CD4+ cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4+ Cell counts and HIV RNA levels during follow-up. In: The Journal of infectious diseases, 2008, vol. 197, n° 8, p. 1145–1155. doi: 10.1086/529523
Main files (1)
Article
Identifiers
- PID : unige:19145
- DOI : 10.1086/529523
- PMID : 18476293
Additional URL for this publicationhttp://jid.oxfordjournals.org/content/197/8/1145.full.pdf
Journal ISSN0022-1899